AI assistant
CSL Ltd. — Regulatory Filings 2021
Dec 2, 2021
17854_rns_2021-12-02_a1dc295e-3491-4018-8e0c-ae009a973418.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
For immediate release
3 December 2021
==> picture [205 x 32] intentionally omitted <==
==> picture [58 x 30] intentionally omitted <==
==> picture [262 x 27] intentionally omitted <==
Response to speculation
CSL Limited (ASX:CSL; USOTC:CSLLY) notes the recent speculation about CSL's involvement in potential offshore M&A activity.
CSL regularly assesses strategic opportunities that can improve its business, improve the health of people around the world and provide value to shareholders.
There is no certainty that any transaction will result from CSL's consideration of such opportunities and, if any transaction does result, when such a transaction would occur.
CSL will keep the market informed in accordance with its continuous disclosure obligations, and otherwise does not intend to comment on such matters.
Authorised by Fiona Mead Company Secretary
FURTHER INFORMATION
For further information, please contact:
Investors: Mark Dehring Head of Investor Relations CSL Limited Telephone: +613 9389 3407 Email: [email protected]
Media: Jemimah Brennan Head of Communications, Asia Pacific CSL Limited Mobile +61 412 635 483 Email: [email protected]
==> picture [99 x 7] intentionally omitted <==